California, US AI start-up Profluent has signed a major alliance with pharma group Eli Lilly, worth up to $2.25 billion, that ...

Automation is key to ensuring long-term success. Embracing automation is a critical business decision; it will streamline ...

From effective panellist recruitment and robust validation, to precision targeting and enhanced engagement, discover how a ...

Novartis has started to show the effects of its patent cliff more strongly, with sales and profits falling in the first ...

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a ...

After years of wrangling, OxyContin manufacturer Purdue Pharma is on the brink of a bankruptcy agreement that could allow it ...

As a tech lover, I soak it all in and leave inspired about what’s next. This was the case recently when I attended Google ...

Results from a late-stage trial of Boehringer Ingelheim and Zealand Pharma's GLP-1 and glucagon agonist drug survodutide ...

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine a medicine with digital ...

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with John Holodnak, co-founder of Occam, about how AI is ...

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over ...

The launch of a new national research collaboration focused on Parkinson’s disease has been announced. The Parkinson’s ...